IBM opens drug discovery database to the NIH

12/13/2011 | Pharmaceutical Business Review Online · iHealthBeat

IBM will open its database of about 2.4 million chemical compounds to the NIH for research. AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer collaborated with IBM to compile the database based on millions of patent filings and journal abstracts published between 1976 and 2000.

View Full Article in:

Pharmaceutical Business Review Online · iHealthBeat

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC